当前位置: X-MOL 学术Pharmaceutics › 论文详情
Our official English website, www.x-mol.net, welcomes your feedback! (Note: you will need to create a separate account there.)
Cyclodextrin Diethyldithiocarbamate Copper II Inclusion Complexes: A Promising Chemotherapeutic Delivery System against Chemoresistant Triple Negative Breast Cancer Cell Lines
Pharmaceutics ( IF 4.9 ) Pub Date : 2021-01-10 , DOI: 10.3390/pharmaceutics13010084
Ammar Said Suliman , Mouhamad Khoder , Ibrahim Tolaymat , Matt Webster , Raid G. Alany , Weiguang Wang , Abdelbary Elhissi , Mohammad Najlah

Diethyldithiocarbamate Copper II (DDC-Cu) has shown potent anticancer activity against a wide range of cancer cells, but further investigations are hindered by its practical insolubility in water. In this study, inclusion complexes of DDC-Cu with hydroxypropyl beta-cyclodextrin (HP) or sulfobutyl ether beta-cyclodextrin (SBE) were prepared and investigated as an approach to enhance the apparent solubility of DDC-Cu. Formulations were prepared by simple mixing of DDC-Cu with both cyclodextrin (CDs) at room temperature. Phase solubility assessments of the resulting solutions were performed. DDC-Cu CD solutions were freeze-dried for further characterisations by DSC, thermogravimetric analysis (TGA) and FT-IR. Stability and cytotoxicity studies were also performed to investigate the maintenance of DDC-Cu anticancer activity. The phase solubility profile deviated positively from the linearity (Ap type) showing significant solubility enhancement of the DDC-Cu in both CD solutions (approximately 4 mg/mL at 20% w/w CD solutions). The DSC and TGA analysis confirmed the solid solution status of DDC-Cu in CD. The resulting solutions of DDC-Cu were stable for 28 days and conveyed the anticancer activity of DDC-Cu on chemoresistant triple negative breast cancer cell lines, with IC50 values less than 200 nM. Overall, cyclodextrin DDC-Cu complexes offer a great potential for anticancer applications, as evidenced by their very positive effects against chemoresistant triple negative breast cancer cells.

中文翻译:

环糊精二乙基二硫代氨基甲酸酯铜II包合物:对化学抗性三阴性乳腺癌细胞系的有前途的化学传递系统。

二乙基二硫代氨基甲酸酯铜II(DDC-Cu)对多种癌细胞均显示出有效的抗癌活性,但由于其在水中的实际不溶性,进一步的研究受到了阻碍。在这项研究中,制备了DDC-Cu与羟丙基β-环糊精(HP)或磺丁基醚β-环糊精(SBE)的包合物,并以此作为提高DDC-Cu表观溶解度的方法。通过在室温下将DDC-Cu与两种环糊精(CD)简单混合来制备制剂。对所得溶液进行相溶解度评估。将DDC-Cu CD溶液冷冻干燥,以通过DSC,热重分析(TGA)和FT-IR进行进一步表征。还进行了稳定性和细胞毒性研究,以研究DDC-Cu抗癌活性的维持情况。w / w CD解决方案)。DSC和TGA分析证实了DDC-Cu在CD中的固溶状态。所得的DDC-Cu溶液稳定28天,并传达了DDC-Cu对化学抗性三阴性乳腺癌细胞系的抗癌活性,IC 50值小于200 nM。总体而言,环糊精DDC-Cu复合物为抗癌应用提供了巨大潜力,其对化学耐药性三阴性乳腺癌细胞的非常积极的作用证明了这一点。
更新日期:2021-01-10
down
wechat
bug